2094 Randomized controlled trial on the skin toxicity of panitumumab in third line treatment of KRAS Exon2 wild-type metastatic colorectal cancer: HGCSG1001 (Japanese Skin Toxicity Evaluation Protocol With Panitumumab: J-STEPP): Updated analysis of anti-tumor efficacy. (September 2015)

• Record Type: Journal Article
• Authors: Kobayashi, Y.; Yuki, S.; Kawamoto, Y.; Sawada, K.; Miyagishima, T.; Ehira, N.; Iwanaga, I.; Okuda, H.; Tateyama, M.; Tsuji, Y.; Hatanaka, K.; Nakamura, M.; Kudo, M.; Fukushima, H.; Tagaki, T.; Hisai, H.; Koike, M.; Abe, R.; Sakata, Y.; Komatsu, Y.
• Is Part Of: European journal of cancer. Volume 51:(2015)Supplement 3
• Page Start: S359
• Publication Date: 2015-09
• Subjects: Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Cancer; Tumors; Electronic journals; Periodicals; Electronic journals; 616.994
• DOI: 10.1016/S0959-8049(16)31016-4
• Languages: English
• ISSNs: 0959-8049